产地国家:美国处 方药:是所属类别:5毫克/胶囊 30胶囊/瓶包装规格:5毫克/胶囊 30胶囊/瓶计价单位:瓶生产厂家中文参考译名:安斯泰来生产厂家英文名:Astellas原产地英文商品名:ASTAGRAF XL 5mg/capsules 30capsules/bottle原产地英文药品名:tacrolimus extended-release中文参考商品译名:ASTAGRAF缓释胶囊 5毫克/胶囊 30胶囊...
戊戌数据药品标准数据库提供了Tacrolimus Capsules他克莫司胶囊美国药典标准的查询检索,包括Tacrolimus Capsules他克莫司胶囊美国药典的版本USP36-NF31页码,以及药典的查询与下载.
5.日本价格 原研药规格1:(1mg/瓶) 16145.60日元 原研药规格2:(0.5mg/瓶) 6465.25日元 原研药规格2:(5mg/瓶) 32,7688.70日元 仿制药:暂无资料6.孟加拉价格原研药:暂无资料 仿制药:暂无资料 7.土耳其价格 原研药:暂无资料 仿制药:暂无资料 [caption id="attachment_31269" align="aligncenter" width="300"...
Mylimus 1 Capsule 与其他药物一起使用,以防止您的身体在移植后排斥新器官(例如,肝脏、肾脏或心脏)。它通过削弱你身体的免疫系统来做到这一点,因此它不会攻击新器官。这种药物属于一类称为免疫抑制剂的药物。 ¥350–¥750 产品规格 0.5mg*60s 1mg*60s ...
tacrolimus 1 mg capsule, immediate-release Color: greenShape: oblongImprint: SAL 721 This medicine is a white brown, oblong, capsule imprinted with "logo" and "644". tacrolimus 5 mg capsule, immediate-release Color: dark grayish redShape: oblongImprint: 5MG RDY 527 ...
Mylimus 1 Capsule 与其他药物一起使用,以防止您的身体在移植后排斥新器官(例如,肝脏、肾脏或心脏)。它通过削弱你身体的免疫系统来做到这一点,因此它不会攻击新器官。这种药物属于一类称为免疫抑制剂的药物。 ¥350–¥750 产品规格 0.5mg*60s 1mg*60s ...
The 0.5 mg capsule shell contains ferric oxide yellow, gelatin USP-NF and titanium dioxide USP, the 1 mg capsule shell contains gelatin USP-NF and titanium dioxide USP, and the 5 mg capsule shell contains ferric oxide red, gelatin USP-NF, and titanium dioxide USP. Contains no ingredient ...
lactose monohydrate NF, and magnesium stearate NF. The 0.5 mg capsule shell contains ferric oxide NF, gelatin NF and titanium dioxide USP, the 1 mg capsule shell contains gelatin NF and titanium dioxide USP, and the 5 mg capsule shell contains ferric oxide NF, gelatin NF, and titanium dioxid...
Tacrolimus is a fungal metabolite extracted by Fujisawa Pharmaceutical Co., Ltd in 1982. Due to the immunosuppressive activity, tacrolimus injection and capsule are potent immunosuppressants, and useful in prevention of rejection after organ transplantation. At a molecular level, the immunosuppressive effe...
For patients with the CYP3A5*1*1 allele, the required dose was 2 mg tacrolimus q12h with a Wuzhi capsule, and for patients with the CYP3A5*1*3 allele, the required dose was 3 mg of tacrolimus q12h or 4 mg q24h co-administered with a Wuzhi capsule. This model could be employed to...